Praxis Precision Medicines (PRAX) Retained Earnings (2019 - 2026)

Praxis Precision Medicines' Retained Earnings history runs 8 years deep, the most recent figure standing at -$1.6 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 341.88% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$1.6 million (down 341.88% YoY), while the FY2025 annual figure was $563000.0, up 100.07% from the prior year.
• Retained Earnings was -$1.6 million for Q1 2026 at Praxis Precision Medicines, down from $563000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $659000.0 in Q1 2025 to a low of -$1.1 billion in Q3 2025.
• Historically, Retained Earnings has averaged -$528.3 million across 5 years, with a median of -$602.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings tumbled 890900.0% in 2022, then soared 100.1% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$530.6 million in 2022, then fell by 23.23% to -$653.9 million in 2023, then retreated by 27.96% to -$836.7 million in 2024, then jumped by 100.07% to $563000.0 in 2025, then tumbled by 383.13% to -$1.6 million in 2026.
• The last three Retained Earnings figures came in at -$1.6 million (Q1 2026), $563000.0 (Q4 2025), and -$1.1 billion (Q3 2025), per Business Quant data.